The Sleeping Beauty transposon system: A non-viral vector for gene therapy

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

Over the past decade, the Sleeping Beauty (SB) transposon system has been developed as the leading nonviral vector for gene therapy. This vector combines the advantages of viruses and naked DNA. Here we review progress over the last 2 years in vector design, methods of delivery and safety that have supported its use in the clinic. Currently, the SB vector has been validated for ex vivo gene delivery to stem cells, including T-cells for the treatment of lymphoma. Progress in delivery of SB transposons to liver for treatment of various systemic diseases, such as hemophilia and mucopolysaccharidoses types I and VII, has encountered some problems, but even here progress is being made.

Original languageEnglish (US)
Article numberddr140
Pages (from-to)R14-R20
JournalHuman molecular genetics
Volume20
DOIs
StatePublished - Apr 1 2011

Fingerprint

Beauty
Genetic Therapy
Mucopolysaccharidosis VII
Mucopolysaccharidosis I
DNA Viruses
T-Cell Lymphoma
Hemophilia A
Stem Cells
Safety
Liver
Therapeutics
Genes

Cite this

@article{7319e46c41bd4db6a75d358e6276309d,
title = "The Sleeping Beauty transposon system: A non-viral vector for gene therapy",
abstract = "Over the past decade, the Sleeping Beauty (SB) transposon system has been developed as the leading nonviral vector for gene therapy. This vector combines the advantages of viruses and naked DNA. Here we review progress over the last 2 years in vector design, methods of delivery and safety that have supported its use in the clinic. Currently, the SB vector has been validated for ex vivo gene delivery to stem cells, including T-cells for the treatment of lymphoma. Progress in delivery of SB transposons to liver for treatment of various systemic diseases, such as hemophilia and mucopolysaccharidoses types I and VII, has encountered some problems, but even here progress is being made.",
author = "Aronovich, {Elena L.} and McIvor, {R. Scott} and Hackett, {Perry B.}",
year = "2011",
month = "4",
day = "1",
doi = "10.1093/hmg/ddr140",
language = "English (US)",
volume = "20",
pages = "R14--R20",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",

}

TY - JOUR

T1 - The Sleeping Beauty transposon system

T2 - A non-viral vector for gene therapy

AU - Aronovich, Elena L.

AU - McIvor, R. Scott

AU - Hackett, Perry B.

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Over the past decade, the Sleeping Beauty (SB) transposon system has been developed as the leading nonviral vector for gene therapy. This vector combines the advantages of viruses and naked DNA. Here we review progress over the last 2 years in vector design, methods of delivery and safety that have supported its use in the clinic. Currently, the SB vector has been validated for ex vivo gene delivery to stem cells, including T-cells for the treatment of lymphoma. Progress in delivery of SB transposons to liver for treatment of various systemic diseases, such as hemophilia and mucopolysaccharidoses types I and VII, has encountered some problems, but even here progress is being made.

AB - Over the past decade, the Sleeping Beauty (SB) transposon system has been developed as the leading nonviral vector for gene therapy. This vector combines the advantages of viruses and naked DNA. Here we review progress over the last 2 years in vector design, methods of delivery and safety that have supported its use in the clinic. Currently, the SB vector has been validated for ex vivo gene delivery to stem cells, including T-cells for the treatment of lymphoma. Progress in delivery of SB transposons to liver for treatment of various systemic diseases, such as hemophilia and mucopolysaccharidoses types I and VII, has encountered some problems, but even here progress is being made.

UR - http://www.scopus.com/inward/record.url?scp=79955990614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955990614&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddr140

DO - 10.1093/hmg/ddr140

M3 - Article

C2 - 21459777

AN - SCOPUS:79955990614

VL - 20

SP - R14-R20

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

M1 - ddr140

ER -